恒瑞医药注射用甲苯磺酸瑞马唑仑上市许可申请获受理

Core Viewpoint - Heng Rui Medicine has received acceptance for its drug application for injectable remimazolam tosylate from the National Medical Products Administration, indicating progress in its development for sedation during mechanical ventilation in intensive care settings [1] Group 1 - The drug's approved indications include sedation and anesthesia for non-intubated surgeries and procedures, as well as induction and maintenance of general anesthesia [1]